Addressing antibiotic resistance is more critical than ever
19 December 2020
Pandemic-level infectious diseases that have plagued mankind for centuries are sometimes called ‘the enemy we cannot see’. While years of relentless research and innovation, like the discovery of antibiotics, addressed this problem, a more ominous one emerged.
This is antimicrobial resistance (AMR) and the emergence of superbugs or the development of multidrug-resistant organisms.
Further reading: BMPlus
Author(s): BMPlus
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
